BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34800879)

  • 21. Inhibition of proliferation and induction of autophagy by atorvastatin in PC3 prostate cancer cells correlate with downregulation of Bcl2 and upregulation of miR-182 and p21.
    Peng X; Li W; Yuan L; Mehta RG; Kopelovich L; McCormick DL
    PLoS One; 2013; 8(8):e70442. PubMed ID: 23936432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RWJ-241947 (MCC-555), a unique peroxisome proliferator-activated receptor-gamma ligand with antitumor activity against human prostate cancer in vitro and in beige/nude/ X-linked immunodeficient mice and enhancement of apoptosis in myeloma cells induced by arsenic trioxide.
    Kumagai T; Ikezoe T; Gui D; O'Kelly J; Tong XJ; Cohen FJ; Said JW; Koeffler HP
    Clin Cancer Res; 2004 Feb; 10(4):1508-20. PubMed ID: 14977855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KLF9, a transcription factor induced in flutamide-caused cell apoptosis, inhibits AKT activation and suppresses tumor growth of prostate cancer cells.
    Shen P; Sun J; Xu G; Zhang L; Yang Z; Xia S; Wang Y; Liu Y; Shi G
    Prostate; 2014 Jun; 74(9):946-58. PubMed ID: 24737412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of arsenic trioxide alone and in combination with bortezomib in multiple myeloma RPMI 8266 cells.
    Elmahi AY; Niu C; Li W; Li D; Wang GJ; Hao SS; Cui JW
    Asian Pac J Cancer Prev; 2013; 14(11):6469-73. PubMed ID: 24377552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethanol promotes cytotoxic effects of tumor necrosis factor-related apoptosis-inducing ligand through induction of reactive oxygen species in prostate cancer cells.
    Plante MK; Arscott WT; Folsom JB; Tighe SW; Dempsey RJ; Wesley UV
    Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):16-22. PubMed ID: 22986577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A combination of desmopressin and docetaxel inhibit cell proliferation and invasion mediated by urokinase-type plasminogen activator (uPA) in human prostate cancer cells.
    Sasaki H; Klotz LH; Sugar LM; Kiss A; Venkateswaran V
    Biochem Biophys Res Commun; 2015 Aug; 464(3):848-54. PubMed ID: 26182875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergism between arsenic trioxide and cyclopamine in the inhibition of PC3 cell survival via the Hedgehog signaling pathway.
    Xiong YJ; Guo YJ; Gao YR; Li S; Dai ZH; Dong XQ; Xu YF; Liu CQ; Liu ZY
    Neoplasma; 2015; 62(6):894-904. PubMed ID: 26458318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergy between inhibitors of androgen receptor and MEK has therapeutic implications in estrogen receptor-negative breast cancer.
    Naderi A; Chia KM; Liu J
    Breast Cancer Res; 2011 Apr; 13(2):R36. PubMed ID: 21457548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic killing effects of homoharringtonine and arsenic trioxide on acute myeloid leukemia stem cells and the underlying mechanisms.
    Tan M; Zhang Q; Yuan X; Chen Y; Wu Y
    J Exp Clin Cancer Res; 2019 Jul; 38(1):308. PubMed ID: 31307525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of simultaneous administration of arsenic trioxide and microvesicles derived from human bone marrow mesenchymal stem cells on cell proliferation and apoptosis of acute myeloid leukemia cell line.
    Abbaszade Dibavar M; Soleimani M; Atashi A; Rassaei N; Amiri S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S138-S146. PubMed ID: 30600718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of proteasome induces apoptosis in APL cells and increases chemo-sensitivity to arsenic trioxide: Proposing a perception in APL treatment.
    Zamani-Moghaddam N; Mousavi FS; Esmaeili S; Yousefi AM; Safaroghli-Azar A; Bashash D
    Cancer Treat Res Commun; 2021; 26():100284. PubMed ID: 33387871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dihydroartemisinin Sensitizes Human Lung Adenocarcinoma A549 Cells to Arsenic Trioxide via Apoptosis.
    Chen H; Gu S; Dai H; Li X; Zhang Z
    Biol Trace Elem Res; 2017 Oct; 179(2):203-212. PubMed ID: 28261759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of Dopamine Receptor Associated Drugs on the Proliferation and Apoptosis of Prostate Cancer Cell Lines.
    Akbarian F; Dadkhah F; Campbell A; Asadi F; Ahangari G
    Anticancer Agents Med Chem; 2021; 21(9):1160-1171. PubMed ID: 32867661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenoviral-mediated p53 transgene expression sensitizes both wild-type and null p53 prostate cancer cells in vitro to radiation.
    Colletier PJ; Ashoori F; Cowen D; Meyn RE; Tofilon P; Meistrich ME; Pollack A
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1507-12. PubMed ID: 11121656
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Chen ZH; Zhang YL; Yuan B; Chen WJ; Lei GY; Han L
    Clin Transl Oncol; 2023 Jul; 25(7):2127-2137. PubMed ID: 36723786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naringenin-Induced Apoptotic Cell Death in Prostate Cancer Cells Is Mediated via the PI3K/AKT and MAPK Signaling Pathways.
    Lim W; Park S; Bazer FW; Song G
    J Cell Biochem; 2017 May; 118(5):1118-1131. PubMed ID: 27606834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-application of arsenic trioxide may potentiate cytotoxic effects of vinorelbine/docetaxel on neuroblastoma SK-N-SH cells.
    Qi K; Li Y; Huang K; Xiong X; Chuchu F; Zhang C; Weng W
    Biomed Pharmacother; 2019 May; 113():108665. PubMed ID: 30889490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate androgen-regulated gene: a novel potential target for androgen-independent prostate cancer therapy.
    Xu XF; Zhou SW; Zhang X; Ye ZQ; Zhang JH; Ma X; Zheng T; Li HZ
    Asian J Androl; 2006 Jul; 8(4):455-62. PubMed ID: 16763722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of Quercetin and 2-Methoxyestradiol Enhances Inhibition of Human Prostate Cancer LNCaP and PC-3 Cells Xenograft Tumor Growth.
    Yang F; Song L; Wang H; Wang J; Xu Z; Xing N
    PLoS One; 2015; 10(5):e0128277. PubMed ID: 26011145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Change of the cell cycle after flutamide treatment in prostate cancer cells and its molecular mechanism.
    Wang Y; Shao C; Shi CH; Zhang L; Yue HH; Wang PF; Yang B; Zhang YT; Liu F; Qin WJ; Wang H; Shao GX
    Asian J Androl; 2005 Dec; 7(4):375-80. PubMed ID: 16281084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.